Research News

Transcatheter aortic valve replacement enables higher risk patients to be treated, study shows

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6909 (Published 21 December 2015) Cite this as: BMJ 2015;351:h6909
  1. Susan Mayor
  1. 1London

The use of transcatheter aortic valve replacement (TAVR) increased rapidly in Germany from 2007 to 2013, show the findings of a nationwide study in which patients undergoing TAVR were found to be older and at higher procedural risk than those who had valves replaced surgically.1

Surgical aortic valve replacement was the only treatment option for aortic stenosis until 2007, when devices for transcatheter procedures were approved. The effect of the new approach on …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe